Virtual Meeting to be held on July 20 hosted by Needham.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MRUS:
- Zenocutuzumab (Zeno) granted second Breakthrough Therapy Designation by the U.S. Food & Drug Administration
- Merus granted Breakthrough Therapy Designation for zenocutuzumab
- Merus gets breakthrough therapy designation from FDA in NRG1+ pancreatic cancer
- Zenocutuzumab (Zeno) granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration for the treatment of NRG1+ pancreatic cancer
- Merus appoints Greg Perry as CFO